News

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established ...
Participation and membership of key industry and trade associations enriches Teva’s network across the industry in line with our strategic focus areas and, as a partner of choice in the biotech ...
TEVA teams up with Fosun to speed the development of TEV-56278, a novel anti-cancer immunotherapy targeting PD-1+ T cells. Teva (TEVA) Pharmaceutical and Shanghai Fosun Pharmaceutical announced ...
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established ...
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and ...
Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...
The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone.
in Vermilion. The evening’s program is presented by member Bonnie Stout and it will be all about quilted postcards, according to a news release. Members are encouraged to bring show and tell ...
Shopping for the best dog shoes means first accepting one simple truth: Dogs aren’t meant to wear anything on their feet. Unlike collars or harnesses, shoes feel foreign to our pups, so even the ...